Hans Bitter
4Patents
2h-index
26Co-inventors
40Inventor score
Filing activity: Oct 7, 2015 → Sep 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10253086B2 | CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell | Chemistry; Metallurgy | 20 | Active |
| US11149076B2 | CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell | Chemistry; Metallurgy | 5 | Active |
| US10774388B2 | Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof | Physics | 1 | Active |
| US12344657B2 | CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.